胰岛素泵在糖尿病患者围术期的临床应用  

Clinical study of insulin pump for diabetic patients in perioperative period

作　　者：张颖[1] 曾朝阳[1] 田晓年[1] 邹雪琴[1] 肖园园[1] 

机构地区：[1]三峡大学第一临床医学院宜昌市中心人民医院内分泌科,湖北宜昌443003

出　　处：《现代医学》2012年第1期74-76,共3页Modern Medical Journal

摘　　要：目的:研究糖尿病患者围术期应用胰岛素泵持续皮下输注胰岛素(CSII)的临床疗效。方法:将80例围手术期糖尿病患者随机分为治疗组和对照组,每组各40例。治疗组采用CSII治疗(CSII组),对照组采用常规多次皮下注射胰岛素(MSII)治疗(MSII组),比较两组治疗前后的临床指标。结果:治疗后两组各时点血糖均较治疗前显著下降。CSII组达到血糖目标水平所用的时间、血糖达标率、低血糖发生率、术前准备时间、住院时间、感染率均明显低于CSII组(均P<0.05),但两组住院总费用无差异(P>0.05)。结论:CSII在糖尿病患者围手术期中应用的疗效及安全性方面优于MSII。Objective： To evaluate the clinical effects of continuous subcutaneous insulin injection （CSII） by using insulin pump for diabetic patients in perioperative period. Methods： Eighty diabetic patients in perioperative period were divided into treatment group and control group （40 cases in each group）. Treatment group with the use of continuous subcutaneous insulin infusion therapy by using insulin pump（ CSII group）, the control group patients with conventional multiple subcutaneous insulin injection（ MSII group）. The changes of some clinical indexes were compared between the 2 groups before and after the treatment. Results： The blood glucose level of the patients in both groups decreased evidently after the therapy. The duration to achieve the target for blood glucose, the glucose standard rate, the incidence of hypoglycemia, the infection rate, the time of preoperative preparation, the length of hospitalization in the CSII group were obviously lower than those in the MSII group, total expense of hospitalization in CSII group was almost as much as that in MSII. Conclusion： CSII is superior to MSII at clinical effects and safety for diabetic patients in perioperative period.

关 键 词：胰岛素泵 持续皮下输注胰岛素 多次皮下胰岛素注射 围手术期 

分 类 号：R587.1[医药卫生—内分泌] R619.9[医药卫生—内科学]